Group One Trading’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8K | Sell |
26,301
-2,340
| -8% | -$1.41K | ﹤0.01% | 1486 |
|
|
2025
Q1 | $7.73K | Sell |
28,641
-73,446
| -72% | -$19.8K | ﹤0.01% | 1500 |
|
|
2024
Q4 | $53.1K | Buy |
102,087
+3,142
| +3% | +$1.63K | ﹤0.01% | 1213 |
|
|
2024
Q3 | $321K | Sell |
98,945
-49,982
| -34% | -$162K | ﹤0.01% | 592 |
|
|
2024
Q2 | $447K | Sell |
148,927
-35,411
| -19% | -$106K | ﹤0.01% | 496 |
|
|
2024
Q1 | $857K | Buy |
184,338
+25,911
| +16% | +$120K | ﹤0.01% | 364 |
|
|
2023
Q4 | $656K | Sell |
158,427
-2,076
| -1% | -$8.6K | ﹤0.01% | 481 |
|
|
2023
Q3 | $482K | Buy |
160,503
+23,948
| +18% | +$71.8K | ﹤0.01% | 531 |
|
|
2023
Q2 | $336K | Buy |
136,555
+92,861
| +213% | +$228K | ﹤0.01% | 573 |
|
|
2023
Q1 | $98.7K | Sell |
43,694
-99,841
| -70% | -$226K | ﹤0.01% | 865 |
|
|
2022
Q4 | $501K | Buy |
+143,535
| New | +$501K | ﹤0.01% | 543 |
|
|
2022
Q3 | – | Sell |
-3,354
| Closed | -$64K | – | 2993 |
|
|
2022
Q2 | $64K | Buy |
+3,354
| New | +$64K | ﹤0.01% | 1211 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3030 |
|
|
2021
Q4 | – | Sell |
-2,035
| Closed | -$53K | – | 3111 |
|
|
2021
Q3 | $53K | Sell |
2,035
-5,185
| -72% | -$135K | ﹤0.01% | 1527 |
|
|
2021
Q2 | $231K | Buy |
7,220
+1,000
| +16% | +$32K | ﹤0.01% | 1058 |
|
|
2021
Q1 | $219K | Buy |
+6,220
| New | +$219K | ﹤0.01% | 1006 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2433 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2306 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2124 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2038 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2027 |
|